Celltrion
Incheon, KR Β· 3 known investors
Celltrion is a biopharmaceutical company that researches, develops, manufactures, and markets biosimilars and novel biologic therapeutics across therapeutic areas including immunology, oncology, hematology, ophthalmology, and endocrinology. Its products include ZYMFENTRA (subcutaneous infliximab) for inflammatory bowel disease and a range of FDA-approved biosimilars.
BiotechMedical Devices
Investors Β· 3
Frequently asked questions
- What does Celltrion do?
- Celltrion is a biopharmaceutical company that researches, develops, manufactures, and markets biosimilars and novel biologic therapeutics across therapeutic areas including immunology, oncology, hematology, ophthalmology, and endocrinology. Its products include ZYMFENTRA (subcutaneous infliximab) for inflammatory bowel disease and a range of FDA-approved biosimilars.
- Who are Celltrion's investors?
- Celltrion's investors include Atinum Investment Co. Ltd., IMM Investment Japan, One Equity Partners.
- Where is Celltrion headquartered?
- Celltrion is headquartered in Incheon, KR.